Company Overview and News

11
The Zacks Analyst Blog Highlights: First Trust Nasdaq, PowerShares S&P, SPDR S&P Oil, iShares U.S. Oil and PowerShares Dynamic Energy

2018-05-23 zacks
Chicago, IL – May 23, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include First Trust Nasdaq Oil & Gas ETF (FTXN - Free Report) , PowerShares S&P SmallCap Energy Fund (PSCE - Free Report) , SPDR S&P Oil & Gas Exploration & Production ETF (XOP - Free Report) , iShares U.
TPOYY EQC KMI.WS MPX XOP TAPOF KMI.PRA KMI EQC.PRD EQCO IEO MRO TAP KMR CVB KMRFZ CMCO

139
Tap Oil with Best Energy ETFs & Stocks YTD

2018-05-22 zacks
Oil price has been on a solid run in the past couple of months with Brent hovering near $80 per barrel, the highest since 2014, and U.S. crude trading above $72 per barrel. The rally has been driven by several factors that point to a rebalancing of the oil market and increase in investors’ optimism. In particular, Iran and Venezuela are playing an important role in driving oil price higher. This is especially true as Donald Trump finally withdrew from the Obama-era 2015 nuclear deal and vowed to re-impose all the powerful economic sanctions against the OPEC nation within the deal as well as bring new ones.
TAPOF TPOYY DNR SDRL PFIE IEO XOP TAP PES AKAM

10
Should You Invest in the iShares U.S. Oil & Gas Exploration & Production ETF (IEO)?

2018-05-15 zacks
If you're interested in broad exposure to the Energy - Exploration segment of the U.S. equity market, look no further than the iShares U.S. Oil & Gas Exploration & Production ETF (IEO - Free Report) , a passively managed exchange traded fund launched on 05/01/2006.
COP GD IEO CSX XOP VLO FIDU EOG

17
ETFs & Stocks in Focus as Trump Reimposes Sanction on Iran

2018-05-09 zacks
After months of speculation, Donald Trump finally withdrew from the Obama-era 2015 nuclear deal reached between Iran and six major powers. It also vowed to reimpose all the "powerful economic sanctions” on the OPEC nation waivered within the deal as well as introduce new ones. The sanctions would be reinstated after wind-down periods of 90 and 180 days so that companies could pull out themselves from agreements with Iran to avoid U.
USO GULF CVX XOP UGA ITA

0
XOP / SPDR S&P Oil & Gas Exploration & Production ETF / BlackRock Inc. - null (Passive Investment)

2018-05-08 sec.gov
us78464a7303_050318.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4) SPDR S&P Oil & Gas Exploration & Production ETF -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 78464A730 -------------------------------------------------------- (CUSIP Number) April 30, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *T
XOP

0
XOP / SPDR S&P Oil & Gas Exploration & Production ETF / BlackRock Inc. - null (Passive Investment)

2018-05-08 sec.gov
us78464a7303_050318.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4) SPDR S&P Oil & Gas Exploration & Production ETF -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 78464A730 -------------------------------------------------------- (CUSIP Number) April 30, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *T
XOP

36
Should You Invest in the iShares U.S. Oil & Gas Exploration & Production ETF (IEO)?

2018-04-26 zacks
The iShares U.S. Oil & Gas Exploration & Production ETF (IEO - Free Report) was launched on 05/01/2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Energy - Exploration segment of the U.S. equity market.
COP FMAT FDIS IEO XOP VLO ADM EOG

21
Construct Your Oil Portfolio: The Capital Appreciation Version

2018-04-23 seekingalpha
This is Part 3 of a three-piece series aiming to take a long, hard look at how to go about building an oil stock portfolio that fits your personality.
PBEGF GST-A GST-B GST MVN HKRCP XOP HK.WS GPRK CNNEF EGRGF ESTE GST.PRA GST.PRB CNE ROSEU HK AMR MDLNF JAG PENYF ROSE

4
Should You Invest in the iShares U.S. Oil & Gas Exploration & Production ETF (IEO)?

2018-04-19 zacks
Looking for broad exposure to the Energy - Exploration segment of the U.S. equity market? You should consider the iShares U.S. Oil & Gas Exploration & Production ETF (IEO - Free Report) , a passively managed exchange traded fund launched on 05/01/2006.
COP IEO GUSH XOP VLO EOG

38
Oil Price Jumps on Syria Turmoil: ETFs & Stocks to Trade

2018-04-12 zacks
Oil price hit the highest level in three years on fears of a U.S. strike on Syria. With this, oil price jumped nearly 8% so far this week with U.S. crude rising above $67 per barrel while Brent oil climbed to $72 per barrel. Syria Threatens Oil Supply Although Syria is not a key oil producer, the threat of military action in the region triggered concerns about crude flows across the wider Middle East, which is one of the major oil producers and accounts for one-third of the total world’s oil.
USO CTLR MUR.WI MUR XOP CLR CEO

0
XOP / SPDR S&P Oil & Gas Exploration & Production ETF / BlackRock Inc. - null (Passive Investment)

2018-04-06 sec.gov
us78464a7303_040518.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 3) SPDR S&P Oil & Gas Exploration & Production ETF -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 78464A730 -------------------------------------------------------- (CUSIP Number) March 31, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *T
XOP

0
XOP / SPDR S&P Oil & Gas Exploration & Production ETF / BlackRock Inc. - null (Passive Investment)

2018-04-06 sec.gov
us78464a7303_040518.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 3) SPDR S&P Oil & Gas Exploration & Production ETF -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 78464A730 -------------------------------------------------------- (CUSIP Number) March 31, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *T
XOP

29
Can Energy ETFs Rebound on Middle East Tension?

2018-03-21 zacks
Oil price is recoiling this month after ending a five-month streak of gains in February. This is especially true, as some positive sentiments have again started to build up in the oil market, which were under pressure from growing U.S. crude production (read: Oil Sees Strong Start to 2018 in 4 Years: ETFs to Play). In fact, oil price climbed more than 2% in the last trading session buoyed by tensions in the Middle East and the possibility of further falls in Venezuelan output.
BNO USO MS.PRI MS.PRK MS.PRE MS.PRF IEO MS.PRG XOP MS MS.PRA

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to XOP / SPDR S&P Oil & Gas Exploration & Production ETF on message board site Silicon Investor.

NexOptic Technology Corp
CUSIP: 78464A730